HDAC1 and coronary artery disorder: In addition, HDAC1 inhibition of miR‐182 expression in CHD rat cardiomyocytes leads to the activation of transforming growth factor‐β and small mothers against the decapentaplegic (SMAD) pathway, which promotes the expression of CHD [64].